Antibiogram of Salmonella Isolates: Time to Consider Antibiotic Salvage
- PMID: 27437211
- PMCID: PMC4948387
- DOI: 10.7860/JCDR/2016/18102.7753
Antibiogram of Salmonella Isolates: Time to Consider Antibiotic Salvage
Abstract
Introduction: Enteric fever is a major problem especially in developing countries. Timely and appropriate treatment plays a very important role in reducing the mortality. Fluoroquinolones and cephalosporins are the treatment options for enteric fever. Recent studies have shown that it is time to reconsider the use of earlier antibiotics.
Aim: The study was aimed to know whether salvage is possible and to avoid treatment failures following fluoroquinolone usage.
Materials and methods: A one year retrospective data of Salmonella species isolated from 319 blood samples from our hospital and other diagnostic centers were studied. Demographic data, organism isolated and their changing pattern of antibiogram were analysed.
Results: Out of 319 Salmonella isolates, 52.4% (167) was Salmonella typhi (S. typhi) and 47.6% (152) Salmonella paratyphi A (S. paratyphi A), with a male preponderance. Most of the salmonellae were isolated in the months of June and July, with the majority being in the 1-10 and 21-30 years age groups. Both species were highly susceptible to chloramphenicol (95.2% and 100%) followed by third generation cephalosporins (97% and 98%), cotrimoxazole (95.8% and 98.6%) and ampicillin (94.6% and 93.4%) respectively. Highest resistance was seen for nalidixic acid (90.4% and100%) among both S. typhi and S. paratyphi A isolates followed by ciprofloxacin (62.2% and 54.6%) respectively. MDR to first line drugs was observed in a small proportion of S. typhi (1.7%) only.
Conclusion: The frequency of isolation of S. typhi and S. paratyphi A are in equal proportion and enteric fever is more prevalent in younger age group. It is ideal to adopt bivalent vaccination in Universal immunization schedule. The isolates show sensitivity to first line drugs, paving the way for salvage of the earlier drugs. Cephalosporins still remain the treatment of choice in MDR salmonella isolates.
Keywords: Cephalosporins; MDR; NAR; Salmonella paratyphi A; Salmonella typhi.
Similar articles
-
Antibiotic Susceptibility Patterns of Salmonella Typhi and Salmonella Paratyphi in a Tertiary Care Hospital in Islamabad.Cureus. 2020 Sep 3;12(9):e10228. doi: 10.7759/cureus.10228. Cureus. 2020. PMID: 33042671 Free PMC article.
-
Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi and paratyphi A.Indian J Med Microbiol. 2006 Apr;24(2):101-6. doi: 10.4103/0255-0857.25182. Indian J Med Microbiol. 2006. PMID: 16687859
-
Antibiogram of salmonella isolates from blood with an emphasis on nalidixic Acid and chloramphenicol susceptibility in a tertiary care hospital in coastal karnataka: a prospective study.J Lab Physicians. 2012 Jul;4(2):74-7. doi: 10.4103/0974-2727.105585. J Lab Physicians. 2012. PMID: 23440906 Free PMC article.
-
Antimicrobial resistance in Salmonella enterica serovar typhi and paratyphi in South Asia-current status, issues and prospects.Crit Rev Microbiol. 2015;41(4):536-45. doi: 10.3109/1040841X.2014.880662. Epub 2014 Mar 19. Crit Rev Microbiol. 2015. PMID: 24645636 Review.
-
Enteric fever: a travel medicine oriented view.Curr Opin Infect Dis. 2010 Oct;23(5):432-7. doi: 10.1097/QCO.0b013e32833c7ca1. Curr Opin Infect Dis. 2010. PMID: 20613510 Review.
Cited by
-
Glycyrrhizin Attenuates Salmonella enterica Serovar Typhimurium Infection: New Insights Into Its Protective Mechanism.Front Immunol. 2018 Oct 16;9:2321. doi: 10.3389/fimmu.2018.02321. eCollection 2018. Front Immunol. 2018. PMID: 30459751 Free PMC article.
-
Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial.Trials. 2017 Oct 2;18(1):450. doi: 10.1186/s13063-017-2199-6. Trials. 2017. PMID: 28969659 Free PMC article. Clinical Trial.
-
Extensively Drug-Resistant Typhoid Fever: A Call to Action.Indian J Community Med. 2022 Jan-Mar;47(1):153-154. doi: 10.4103/ijcm.ijcm_1008_21. Epub 2022 Mar 16. Indian J Community Med. 2022. PMID: 35368492 Free PMC article. No abstract available.
-
Comprehensive analysis of extensive drug-resistant Salmonella Typhi in Gujarat region, India: genomic findings and prospective alternative therapy.Microbiol Spectr. 2025 Jul;13(7):e0254024. doi: 10.1128/spectrum.02540-24. Epub 2025 May 27. Microbiol Spectr. 2025. PMID: 40422861 Free PMC article.
-
Clinical Profile and the Role of Rapid Serological Tests: Typhifast IgM and Enterocheck WB in the Diagnosis of Typhoid Fever.Indian J Crit Care Med. 2020 May;24(5):307-312. doi: 10.5005/jp-journals-10071-23417. Indian J Crit Care Med. 2020. PMID: 32728320 Free PMC article.
References
-
- Muthu G, Suresh A, Sumathy G, Srivani R. Studies on antimicrobial susceptibility pattern of salmonella isolates from Chennai, India. Int J Pharm Bio Sci. 2011;2(2):435–42.
-
- Zaki SA, Karade S. Multidrug-resistant typhoid fever: a review. J Infect Dev Ctries. 2011;5(5):324–37. - PubMed
-
- Usman SM, Rashmi M. An insight into contemporary trend in the antibiogram of salmonella enteric serovars: A clamor for antibiotic recycling. J of Evolution of Med and Dent Sci. 2013;2(44):8468–73.
-
- Nagshetty K, Channappa ST, Gaddad SM. Antimicrobial susceptibility of Salmonella typhi in India. J Infect Dev Ctries. 2010;4(2):70–73. - PubMed
-
- WHO: Background document: The diagnosis, treatment and prevention of typhoid fever. Geneva, World Health Organization Communicable Disease Surveillance and Response. WHO/VandB/03.07;2003.
LinkOut - more resources
Full Text Sources
Other Literature Sources